Stock QLI QILIAN INTERNATIONAL HOLDING GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Qilian International Holding Group Limited

Equities

QLI

KYG7307E1237

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 12:05:30 28/06/2024 am IST 		5-day change 1st Jan Change
3.04 USD -0.33% Intraday chart for Qilian International Holding Group Limited -31.89% -21.18%
04/06 Qilian International Holding Group Limited Announces Board and Committee Changes CI
04/06 Qilian International Holding Group Limited Announces Chief Financial Officer Changes CI

Business Summary

Qilian International Holding Group Ltd is a China-based company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. Its main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.

Number of employees: 298

Sales per Business

USD in Million2022Weight2023Weight Delta
Oxytetracycline and Licorice Products and Traditional Chinese Medicine Derivatives
62.7 %
40 62.1 % 29 62.7 % -27.67%
Heparin Products and Sausage Casing
33.0 %
23 36.2 % 15 33.0 % -34.70%
Fertilizer
4.3 %
1 1.7 % 2 4.3 % +83.77%

Sales per region

USD in Million2022Weight2023Weight Delta
China
100.0 %
65 100.0 % 46 100.0 % -28.35%

Managers

Managers TitleAgeSince
Zhan Chang Xin CEO
 Chief Executive Officer 58 07/19/07
Hai Ping Shi DFI
 Director of Finance/CFO 51 08/20/08

Members of the board

Members of the board TitleAgeSince
Song Gao BRD
 Director/Board Member 56 13/23/13
Zhan Chang Xin CEO
 Chief Executive Officer 58 07/19/07
Hai Ping Shi DFI
 Director of Finance/CFO 51 08/20/08
Ming Jing BRD
 Director/Board Member 61 08/20/08
Ding Qian Liu BRD
 Director/Board Member 55 09/23/09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,750,000 1,612,600 ( 33.95 %) 0 33.95 %

Shareholders

NameEquities%Valuation
Zhan Chang Xin
38.71 %
13,839,000 38.71 % 11 M $
Hai Ping Shi
19.95 %
7,131,000 19.95 % 6 M $
Ding Qian Liu
18.79 %
6,717,000 18.79 % 5 M $
Geode Capital Management LLC
0.0661 %
23,641 0.0661 % 18 913 $
G1 Execution Services LLC
0.0358 %
12,796 0.0358 % 10 237 $
Morgan Stanley Capital Services LLC
0.005018 %
1,794 0.005018 % 1 435 $
UBS Securities LLC
0.000190 %
68 0.000190 % 54 $

Company contact information

Qilian International Holding Group Ltd.

Economic & Technological Dev Zone

735000, Jiuquan

+

http://www.qlsyy.net
address Qilian International Holding Group Limited(QLI)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
QILIAN INTERNATIONAL HOLDING GROUP LIMITED Stock Qilian International Holding Group Limited
-21.18% 21.81M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.95% 811B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.62% 640B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.98% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.08% 333B
ABBVIE INC. Stock AbbVie Inc.
+9.05% 302B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.30% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+2.41% 225B
NOVARTIS AG Stock Novartis AG
+12.47% 218B
AMGEN INC. Stock Amgen Inc.
+8.91% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. QLI Stock
  4. Company Qilian International Holding Group Limited